Related references
Note: Only part of the references are listed.Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
An Claes et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-α in an animal model of inflamed Alzheimer's disease brain
Jae K. Ryu et al.
NEUROBIOLOGY OF DISEASE (2008)
Pathophysiology of the blood-brain barrier: Animal models and methods
Brian T. Hawkins et al.
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 80 (2008)
Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling
Yoko Hasumi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model
Susan Murphy et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Hubing Shi et al.
BLOOD (2007)
Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo
Tao Zhang et al.
LIFE SCIENCES (2007)
MRI of tumor angiogenesis
Tristan Barrett et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
Angiogenesis in brain tumours
Rakesh K. Jain et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Intraperitoneal injection of a hairpin RNA - Expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice
Christopher S. Gondi et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of trichostatin A-induced antianglogenesis by small-interfering RNA for thrombospondin-1
Jung-Hoon Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth
Qing Shi et al.
MOLECULAR CARCINOGENESIS (2007)
Chemotherapy delivery issues in central nervous system malignancy: A reality check
Leslie L. Muldoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma
Svetomir N. Markovic et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Cellular characterization of a novel focal adhesion kinase inhibitor
Jill K. Slack-Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of VEGFR3 in glioma endothelium correlates with tumor grade
S. J. Grau et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma
Qiwei Yang et al.
CANCER RESEARCH (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood
Dan G. Duda et al.
NATURE PROTOCOLS (2007)
Type IV collagen-derived angiogenesis inhibitors
Thomas M. Mundel et al.
MICROVASCULAR RESEARCH (2007)
Effect of the angiogenesis inhibitor cilengitide (EMD 121974) on glioblastoma growth in nude mice
Shinya Yamada et al.
NEUROSURGERY (2006)
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes
Manish Aghi et al.
CANCER RESEARCH (2006)
New concepts regarding focal promotion of cell migration adhesion kinase and proliferation
Braden D. Cox et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
Patrick Y. Wen et al.
CLINICAL CANCER RESEARCH (2006)
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
Patrizia Mancuso et al.
BLOOD (2006)
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer
Balazs Dome et al.
CANCER RESEARCH (2006)
Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses
Marcela Assanah et al.
JOURNAL OF NEUROSCIENCE (2006)
Different angiogenic phenotypes in primary and secondary glioblastomas
S Karcher et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Antiangiogenic activity of BAI1 in vivo:: implications for gene therapy of human glioblastomas
X Kang et al.
CANCER GENE THERAPY (2006)
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
L Eklund et al.
EXPERIMENTAL CELL RESEARCH (2006)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
CM Overall et al.
NATURE REVIEWS CANCER (2006)
HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells
M Natarajan et al.
ONCOGENE (2006)
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D
BA Moffat et al.
CLINICAL CANCER RESEARCH (2006)
Involvement of phosphatidylserine, αvβ3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages
A Böttcher et al.
ARTHRITIS AND RHEUMATISM (2006)
Stress induction of GRP78/BiP and its role in cancer
JZ Li et al.
CURRENT MOLECULAR MEDICINE (2006)
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastorna multiforme
DA Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas
G Pradilla et al.
NEUROSURGERY (2005)
Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model
CY Fears et al.
CANCER RESEARCH (2005)
Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated
ML Wahl et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
The role of pericytes in blood-vessel formation and maintenance
G Bergers et al.
NEURO-ONCOLOGY (2005)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression
SR Perri et al.
CANCER RESEARCH (2005)
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
R Hoekstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases
R Heljasvaara et al.
EXPERIMENTAL CELL RESEARCH (2005)
In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment
AJ Quesada et al.
CELL DEATH AND DIFFERENTIATION (2005)
Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78
DJ Davidson et al.
CANCER RESEARCH (2005)
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor
B Kaur et al.
ONCOGENE (2005)
The tyrosine kinase Pyk2 promotes migration and invasion of glioma cells
CA Lipinski et al.
NEOPLASIA (2005)
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities
F Haviv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells
A Zernecke et al.
CIRCULATION RESEARCH (2005)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
DJ Brat et al.
NEURO-ONCOLOGY (2005)
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
B Kaur et al.
NEURO-ONCOLOGY (2005)
P27Kip and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain
Q Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of the thrombospondin 1 fragment 167-569 in C6 glioma cells stimulates tumorigenicity despite reduced neovascularization
F de Fraipont et al.
ONCOGENE (2004)
Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors
B Annabi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking αvβ5 integrin
JT Koh et al.
EXPERIMENTAL CELL RESEARCH (2004)
Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme
F Baumann et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model
NO Schmidt et al.
CLINICAL CANCER RESEARCH (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option
WPJ Leenders et al.
CLINICAL CANCER RESEARCH (2004)
Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system
A Bikfalvi
BIOCHEMICAL PHARMACOLOGY (2004)
Integrative signaling in angiogenesis
M Simons
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
MA Arap et al.
CANCER CELL (2004)
Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure
FH Barnett et al.
GENE THERAPY (2004)
Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
EM Kemper et al.
CANCER TREATMENT REVIEWS (2004)
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
DJ Ceradini et al.
NATURE MEDICINE (2004)
Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin
G Bix et al.
JOURNAL OF CELL BIOLOGY (2004)
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial
NS Akella et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Regulation of transcription and translation by hypoxia
LP Liu et al.
CANCER BIOLOGY & THERAPY (2004)
The thrombospondins
CAA Josephine et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
The N-terminus of thrombospondin: the domain stands apart
CA Elzie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
JB Rubin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors
P Baluk et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged
Q Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The enigmatic role of angiopoietin-1 in tumor angiogenesis
LJ Metheny-Barlow et al.
CELL RESEARCH (2003)
CD36: A critical anti-angiogenic receptor
R Simantov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis
JD Hood et al.
JOURNAL OF CELL BIOLOGY (2003)
Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4
G Orend et al.
ONCOGENE (2003)
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas
HA Fine et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression
JH Zhao et al.
MOLECULAR CELL (2003)
Role of bone marrow-derived cells in tumor angiogenesis and treatment
RK Jain et al.
CANCER CELL (2003)
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells
DH Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
G Bergers et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Human tumstatin land human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins
A Sudhakar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Loss of pigment epithelium derived factor expression in glioma progression
M Guan et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Platelet-derived growth factor-b enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment
P Guo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells
H Harada et al.
CANCER LETTERS (2003)
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function
BK Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
M Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression
B Kaur et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous system
J Husemann et al.
GLIA (2002)
The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours
M Chekenya et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
IB Lobov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia
AN Witmer et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1
O Salvucci et al.
BLOOD (2002)
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics
FK Reiher et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas
SM Yamada et al.
NEUROLOGICAL RESEARCH (2002)
Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor
OV Volpert et al.
NATURE MEDICINE (2002)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
J Lawler
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3 '-kinase-mediated PKC delta phosphorylation: Role of PKC in angiogenesis
G Gliki et al.
CELL BIOLOGY INTERNATIONAL (2002)
Specific interaction of angiostatin with integrin αvβ3 in endothelial cells
T Tarui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Direct cell adhesion to the angiopoietins mediated by integrins
TR Carlson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas
LL Groft et al.
BRITISH JOURNAL OF CANCER (2001)
Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats
D Zhang et al.
DIABETOLOGIA (2001)
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
P Mancuso et al.
BLOOD (2001)
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects
S Filleur et al.
GENES & DEVELOPMENT (2001)
Tenascin-C in development and disease: gene regulation and cell function
PL Jones et al.
MATRIX BIOLOGY (2000)
Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties
Y Maeshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Distinct antitumor properties of a type IV collagen domain derived from basement membrane
Y Maeshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis
D Zagzag et al.
LABORATORY INVESTIGATION (2000)
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells
M Tenan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Human malignant glioma therapy using anti-alpha(v)beta(3) integrin agents
S Chatterjee et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
B Jimenez et al.
NATURE MEDICINE (2000)
Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma
T Kawataki et al.
NEUROPATHOLOGY (2000)
Share Paper
